血液病科普知识、最新研究进展与患者关怀
本研究发表于《白血病》（Leukemia）杂志，旨在评估一种名为obecabtagene autoleucel（一种嵌合抗原受体T细胞免疫疗法，CAR-T）的新型细胞治疗，对比标准疗法在复发或难治性成人B细胞急性淋巴细胞白血病（B-cell acute lymphoblastic leukemia, B-ALL）患者中的效果。复发/难治性意味着疾病对常规治疗反应不佳或治疗后再次出现。研究采用外部对
Leukemia, Published online: 17 July 2026; doi:10.1038/s41375-026-03068-0Correspondence on Mauro et al.: ensuring meaningful conclusions through data accuracy and consistency
Bispecific T cell engagers (TCE) targeting BCMA or GPRC5D have improved outcomes in relapsed/refractory multiple myeloma (MM), yet up to 40% of patients are primarily refractory, and predictive biomar
Leukemia, Published online: 15 July 2026; doi:10.1038/s41375-026-03065-3JAK2V617F-positive clonal hematopoiesis in germline BRCA1 versus BRCA2 mutation carriers
FAQ
您可能想了解的血液病知识